Integrated positron emission tomography/computed tomography (PET/CT) has many
advantages over solitary PET and CT, which has led it to become an increasingly …

Fluoro-deoxyglucose positron emission tomography (PET) imaging has a diagnostic and
prognostic value in the initial staging, restaging, and surveillance of non–small-cell lung …

PURPOSE: To determine the accuracy of dual-modality positron emission tomographic
(PET)–computed tomographic (CT) imaging, as compared with PET alone and CT alone, in …

Non–small cell lung cancer (NSCLC) accounts for approximately 80% of bronchogenic
malignancies. The choice of therapy options, including surgery, radiation therapy, and …

In the Western world, lung cancer is the leading cause of cancer-related death. Nonsmall
cell lung cancer (NSCLC) accounts for 87% of all lung cancers [1]. Adequate diagnosis and …

Lung cancer is the leading cause of cancer-related death in industrialized countries. The
overall mortality rate for lung cancer is high, and early diagnosis provides the best chance …

Lung cancer remains a leading cause of cancerrelated deaths worldwide, accounting for
approximately 224,390 new patients and 158,080 deaths in 2016, according to the …

Background We compared the diagnostic accuracy of integrated positron-emission
tomography (PET) and computed tomography (CT) with that of CT alone, that of PET alone …

Positron emission tomography (PET)/computed tomographic scanning, using 18F-2-deoxy-
D-glucose, complements conventional imaging evaluation of patients with lung cancer. The …

PURPOSE: To compare the accuracies of whole-body 2-[fluorine 18] fluoro-2-deoxy-d-
glucose (FDG) positron emission tomography (PET) and conventional imaging (thoracic …